Next Article in Journal
Effects of Olive Oil Consumption on Cardiovascular Risk Factors in Patients with Fibromyalgia
Next Article in Special Issue
Biological and Computational Studies for Dual Cholinesterases Inhibitory Effect of Zerumbone
Previous Article in Journal
Moderate Weight Loss Modifies Leptin and Ghrelin Synthesis Rhythms but Not the Subjective Sensations of Appetite in Obesity Patients
Previous Article in Special Issue
Modulation of Adhesion Process, E-Selectin and VEGF Production by Anthocyanins and Their Metabolites in an In Vitro Model of Atherosclerosis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Nutrients
Volume 12
Issue 4
10.3390/nu12040917
nutrients-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Indole-3-Carbinol Inhibits Citrobacter rodentium Infection through Multiple Pathways Including Reduction of Bacterial Adhesion and Enhancement of Cytotoxic T Cell Activity

by
Yanbei Wu
1,2,3,
Qiang He
4,
Liangli Yu
5,
Quynhchi Pham
3,
Lumei Cheung
3,
Young S. Kim
6,
Thomas T. Y. Wang
3,* and
Allen D. Smith
3,*
1
China-Canada Joint Lab of Food Nutrition and Health (Beijing), Beijing Technology & Business University, Beijing 100048, China
2
Beijing Advanced Innovation Center for Food Nutrition and Human Health, Beijing Technology & Business University, Beijing 100048, China
3
Diet, Genomics, and Immunology Laboratory, Beltsville Human Nutrition Research Center, USDA-ARS, Beltsville, MD 20705, USA
4
College of Biomass Science and Engineering, Sichuan University, Chengdu 610065, China
5
Department of Nutrition and Food Science, University of Maryland, College Park, MD 20742, USA
6
Nutritional Science Research Group, Division of Cancer Prevention, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892, USA
*
Authors to whom correspondence should be addressed.
Nutrients 2020, 12(4), 917; https://0-doi-org.brum.beds.ac.uk/10.3390/nu12040917
Submission received: 12 February 2020 / Revised: 13 March 2020 / Accepted: 19 March 2020 / Published: 27 March 2020
(This article belongs to the Special Issue The Effects of Phytochemicals on Health Benefit)
Browse Figures
Review Reports Versions Notes

Abstract

:
Intestinal inflammation is associated with an increased risk of developing colorectal cancer and may result from dysregulated responses to commensal bacteria or exposure to bacterial pathogens. Dietary modulation of intestinal inflammation may protect against development of colon cancer. However, the precise diet-derived components and underlying mechanisms remain elusive. Citrobacter rodentium (Cr) induces acute intestinal inflammation and has been used to study the role of inflammation in the susceptibility to colon cancer. Here we examine the effects of indole-3-carbinol (I3C), a dietary compound with anticarcinogenic properties, on intestinal immune and inflammatory responses to Cr infection and adhesion to colonic cells in vitro. C57BL/6J mice were fed a diet with/without 1 μmol/g I3C and infected with Cr. Compared to infected mice fed with a control diet, consumption of a 1 μmol I3C/g diet significantly reduced fecal excretion of Cr, Cr colonization of the colon, and reduced colon crypt hyperplasia. Furthermore, expression of Cr-induced inflammatory markers such as IL-17A, IL-6, and IL1β were attenuated in infected mice fed with the I3C diet, compared to mice fed a control diet. The expression of cytotoxic T cell markers CD8 and FasL mRNA were increased in I3C-fed infected mice. In-vitro, I3C inhibited Cr growth and adhesion to Caco-2 cells. I3C alleviates Cr-induced murine colitis through multiple mechanisms including inhibition of Cr growth and adhesion to colonic cells in vitro and enhancement of cytotoxic T cell activity.

Graphical Abstract

1. Introduction

Colorectal cancer (CRC) is the fourth most common malignancy and third leading cause of cancer deaths worldwide [1]. It is well documented that intestinal inflammation is one of the most common risk factors associated with CRC tumorigenesis, and is recognized as an important hallmark for CRC development [2,3]. Specific intestinal pathogens such as Streptococcus bovis/gallolyticus, as well as chronic intestinal inflammation caused by inflammatory bowel disease (IBD), were reported to contribute to CRC development [4,5]. Therefore, modulating inflammation in the intestine may influence/protect against development of CRC. Moreover, in most cases, CRC is thought to be caused by environmental factors since only 20–30% of CRC cases are attributed to familial hereditary [6]. Among the environmental factors, diet may be the most critical factor associated with CRC development [7]. Importantly, a diet rich in fruits and vegetables has been reported to exert anti-inflammatory effects in the intestine, and thus may help prevent development of CRC [8]. However, the precise dietary components and their modes of action (i.e., through modulation of inflammatory pathways) that contributed to CRC protective effects remain unclear and warrant further elucidation.
Indole-3-carbinol (I3C), a bioactive compound found in cruciferous vegetables such as broccoli, cabbage and cauliflower, is well known for its cancer protective effects [9,10]. When given orally through the diet or as a supplement, I3C can dimerize into another bio-active compound, 3,3′-diindolylmethane (DIM), under the acidic conditions in the stomach [11]. These indoles have been reported to exert various anti-bacterial, anti-inflammatory, and anti-cancer activities [12,13]. Several nuclear transcriptional factors including the estrogen receptor (ER), nuclear factor-κB (NF-κB), and the aryl hydrocarbon receptor (AhR) are modulated by I3C/DIM and contribute to the maintenance of hormonal homeostasis, inhibition of cell cycle progression/apoptosis, induction of DNA repair, and enhancement of carcinogen metabolism [14]. For example, dietary I3C was reported to regulate intestinal homeostasis via the formation of intestinal lymphoid follicles and the expansion of innate lymphoid cells through AhR-dependent pathways. I3C-derived DIM was found to alleviate oxazolone-induced colitis through Th2/Th17 suppression and T regulatory cell (Treg) induction [15]. These in vivo and in vitro findings support the value of I3C and its derivatives in modulating inflammation, cancer prevention and therapy.
The role of I3C and cruciferous vegetables in modulating pathogen-induced intestinal inflammation, via AhR-dependent signaling, has been reported for the Citrobacter rodentium (Cr) -induced colitis model [16,17]. Cr is a well-known murine mucosal pathogen that shares 67% of its genes with two clinically important human enteric pathogens: enteropathogenic Escherichia coli (EPEC) and enterohemorrhagic E. coli (EHEC) [18]. The Cr infection model shares many aspects of EPEC and EHEC infections in humans including the production of attaching and effacing lesions and the ability to promote colon tumorigenesis in mice [19]. Cr infection induces a variety of changes in the colon including hyperplasia and crypt dilation, epithelial cell proliferation, development of an uneven apical enterocyte surface, and mucosal thickening. Following oral administration, Cr initially colonizes in the caecum and then migrates to the colon with rapid expansion, the Cr excretion usually peaks on day seven post infection, and is gradually cleared by 21–28 days after infection. Both innate and adaptive immunity are important for the clearance of Cr. Resolution of Cr infection involves the recruitment of innate lymphoid cells, neutrophils, macrophages, B cells, T cells and the release of multiple cytokines and antimicrobial peptides [20]. CD4+ T cells, acting through IL-22, play a crucial role as a defense mechanism against Cr infection [21]. However, the T cell-derived cytokines (IL17A, IFN-γ, and TNF) are also known to, either directly or indirectly, contribute to intestinal tissue injury [22]. In addition to T-cells, the group 3 innate lymphoid cells (ILC3s) are also an important source of IL22 and contribute to clearance of Cr. AhR-dependent signaling pathways were also reported to be important in controlling and clearing Cr [23]. The effects of AhR in maintaining intestinal homeostasis were ablated in AhR-deficient mice and resulted in increased susceptibility of mice to Cr infection [15]. However, little information is available relating to the effect of I3C/DIM on bacterial growth and adhesion during Cr infection. Furthermore, the effect of I3C/DIM on CD8+ cells during Cr infection are also not well studied.
To address these questions, we characterized the effects of dietary I3C on the immune response to Cr infection and examined the in vitro effects of I3C on Cr growth and adhesion to a colonic cell line. We found the protective effect of dietary I3C against Cr infection may be through multiple mechanisms that involve modulation of bacterial growth and adhesion as well as the immune response to infection.

2. Materials and Methods

2.1. Animals and Diet

C57BL/6J mice (5-week-old male) were purchased from the Small Animals Division of the National Cancer Institute (Frederick, MD), and were housed in groups of four in ventilated cages with filter-tops at the Beltsville Human Nutrition Center‘s animal facility under a 12-h light cycle. To avoid possible sex effects on the infection, male mice were chosen. All experiments were approved by the USDA/ARS Beltsville Institutional Animal Care and Use Committee (protocol #12-030). Mice were acclimated for one week prior to the onset of dietary treatments. The mice were then randomized into two experimental feeding groups: (i) AIN-93M control diet, (ii) AIN-93M with 1 µmol (147.2 μg) I3C/g diet. The mice were fed the experimental diets for two weeks prior to infection with Cr and for the remainder of the experiment. Food consumption and body weights were recorded weekly.
It has been estimated that a dose of 1 µmol I3C/g diet (147 mg/kg) in mice equates to a human equivalent dose of 11.4 mg/ kg in the average adult human. If estimating this dosage for a 60 kg man, the amount of I3C provided in this study may correspond to the consumption of approximately half a head of cabbage. In a clinical study, administration of I3C supplements was tolerated in doses up to 1200 mg/ day in male and female cancer patients. Our selected concentration of I3C for this study is similar to those amounts consumed in the diet as well as those amounts supported on a low-dose chemopreventive range [24,25,26].

2.2. Cr Infection

The Cr strain used in this study is a nalidixic acid-resistant mutant of strain DBS100 (ATCC 51459). Cr was streaked out from a frozen stock on a Luria-Bertani (LB) agar plate and grown overnight at 37 °C. A colony was picked and used to inoculate LB medium and grown at 37 °C overnight. The following morning the culture was expanded, grown to an OD600 nm of ≈1.5, collected by centrifugation, and re-suspended in LB medium to a concentration of 5 × 1010 CFU/mL. Mice were infected by oral gavage with 0.2 mL of the Cr suspension (1.0 × 1010 CFU) or LB medium only for uninfected mice on either diet. The dose of oral gavage was determined by retrospective plating on LB agar plates containing 50 µg/mL nalidixic acid.

2.3. Sample Collection

Fresh fecal pellets of mice were collected on various days post infection (4, 7, 11, 14, 17, 20). The pellets were homogenized in LB broth, serially diluted, plated on LB/agar plates containing 50 µg/mL nalidixic acid, and incubated at 37 °C overnight. The colonies were enumerated the following day. Mice were sacrificed on day 12 and 21 after infection. The spleen and caecum were removed and weighed. The distal 5 cm of colon was excised and fecal pellets were removed and weighed. One cm portions of the colon were fixed in 4% formalin for histology or snap frozen in liquid nitrogen for gene expression analysis. To measure the degree of Cr colonization on the colon, the remaining colon tissue was weighed, homogenized, and plated on LB/agar plates with 50 µg/mL nalidixic acid. Results are presented as CFUs per gram of feces or colon.

2.4. Measurement of Crypt Depth

Approximately 1 cm portions of distal colon cut from equidistant positions were fixed in 4% formalin and embedded in paraffin before 5-μm sections were cut and stained with hematoxylin and eosin. Colon crypt depth was measured using a Nikon Eclipse E800 microscope (Nikon, Tokyo, Japan) and Nikon NIS-Elements software V4.6 (Nikon, Tokyo, Japan). The mucosal height for each mouse was determined by averaging 12 or more individual well-oriented crypts.

2.5. Measurement of Colonic Cytokine Gene Expression

To analyze gene expression in colon samples, total RNA was isolated using the TRIzol reagent (Life Technology, NY, USA). The concentration and integrity of RNA were measured using a Bioanalyzer (Agilent 2100 Bioanalyzer, Santa Clara, CA, USA). RNA with an integrity number above 8 was used for real-time qRT-PCR. The AffinityScript Multi-temperature cDNA Synthesis kit from Agilent was used to reverse-transcribe mRNA to complementary DNA. Real-time PCR was performed on Applied Biosystems ViiA7 Real-Time PCR System using TaqMan® Gene Expression Assay (Invitrogen, Carlsbad, CA, USA). For evaluation of the treatment effects, genes of interest (Table 1) were normalized to the housekeeping gene TATA-box binding protein (TBP) and analyzed using the ∆∆Ct method. The primers/probes for gene expression analysis below were purchased from Life Technology.

2.6. Antimicrobial Susceptibility Assay

To determine the effects of I3C on Cr growth, Cr was cultured in Luria-Bertani (LB) broth overnight at 37 °C and the bacterial suspension was diluted to 2 × 107 CFU/mL. One mL of the Cr suspension was added to wells of 24-well microtiter plates. Next, I3C (Sigma Chemical Co., St. Louis, MO, USA) was dissolved in ethanol and diluted to 0.5 mM or 1.0 mM in LB medium. For control wells not receiving I3C, LB containing an equivalent amount of ethanol was used. The concentrations of I3C were based on the minimum inhibitory concentration of I3C against the gram-positive bacterial strains previously evaluated by Sung et al [12]. The plates were incubated at 37 °C while on shaker (200 rpm) under aerobic and anaerobic conditions (BD GasPak EZ Anaerobe Gas Generating Pouch System with an indicator). The OD value was determined every hour using a microtiter plate reader (Microbiology International, Frederick, MD, USA).

2.7. Adhesion Assay

The method used to determine adhesion of Cr to Caco-2 cells was a modified procedure described by Cho et al. [27]. Briefly, human colonic Caco-2 cells (ATCC HTB-37) were grown in Dulbecco’s Modified Eagle medium (DMEM) supplemented with 20% (v/v) heat-inactivated fetal bovine serum, 2 mM L-glutamine, and 1% (v/v) antibiotics (100 U/mL penicillin, 100 μg/mL streptomycin). Cells were grown in 75 cm2 tissue culture flasks and incubated at 37 °C in 5% CO2. For consistency, cells at the 3rd passage after thawing from frozen stocks were used. For the adhesion assays, Caco-2 cells were seeded at a density of 1 × 105 cells/well into 24-well microplates and incubated for 2 days to allow formation of a monolayer. One day prior to the assay, the complete medium was replaced with DMEM medium without the supplements. On the day of the assay, the medium was aspirated and replaced with 1 mL of bacteria resuspended at 1 × 106 CFU/mL in freshly, non-supplemented DMEM medium containing various concentrations of I3C or DIM. The plates were then incubated at 37 °C for 1 h followed by four washes with PBS minus Ca2+/Mg2+ and the cells were lysed using 1 mL of cold 0.1% Triton X-100 in pure water. The resulting lysates were diluted (1:10) with PBS, plated on LB agar plates containing 50 µg/mL nalidixic acid, and cultured at 37 °C overnight. The colonies were enumerated the following day.

2.8. Statistcal Analysis

Data for each experimental group are expressed as the mean ± SD. Statistical analysis was performed using GraphPad Prism 7 (2018, GraphPad Software, San Diego, CA, USA). Significant differences in the means were detected using an unpaired Student’s t test (Mann–Whitney test) or one-way ANOVA followed by Fisher’s LSD test. Statistical significance was defined at p ≤ 0.05.

3. Results

3.1. Effect of Cr Infection and I3C Supplement on Food Intake and Body Weight

Figure S1A shows the temporal changes of body weight of uninfected and infected C57/BL mice fed the control or the I3C diet. There were no significant differences in body weight between the four experimental groups. Figure S1B illustrates food intake throughout the study. Although there’s a significant drop in food intake after infection, it was recovered by the end of the experiment, and there were no significant differences in food intake between the four experimental groups.

3.2. Effects of Dietary I3C on Cr Colonization in Feces and Colon

After the oral gavage with Cr, the bacteria initially colonize the caecum, and then are found in significant numbers in the colon by day three post infection [28]. Excretion of Cr peaked on day seven post infection. On day 20 post infection, the number of Cr in the feces of the infected mice were low, and there is no significant difference in fecal Cr excretion between the infected mice fed with the control and the I3C diet (Figure S2). Fecal Cr excretion was reduced in I3C-treated mice on day 11 post infection (Figure 1A). Moreover, the colonic tissue C. rodentium loads in the mice fed with the I3C diet were significantly lower than that in the mice fed by the control diet on day 12 post infection (Figure 1B).

3.3. Effects of Dietary I3C on Colon, Spleen and Cecum Weight in Mice

The effect of Cr infection and I3C treatment on the tissue/body weight ratio of colon, spleen, and caecum are shown in Figure 2A (day 12 post infection) and Figure 2B (day 21 post infection). As expected, colon weight increased in Cr-infected mice. Furthermore, I3C treatment had no effect on the infection-induced increase in colon weight. In addition, no difference was found in spleen or cecum weight between the four treatment groups both on day 12 and day 21 post infection.

3.4. Effects of Dietary I3C on Histologic Changes in Colon of Mice

Colon tissues obtained on day 12 and 21 were processed for H&E staining (Figure S3) and the mucosa height (bottom of crypts to epithelium) was measured. Infected mice had increased mucosa height compared to uninfected mice on both days 12 and 21 post infection but mice fed the I3C diet had reduced mucosal height (Figure 3) on day 12 post infection in comparison with the infected mice fed the control diet. However, there was no significant reduction in the crypt height between infected control- and I3C-fed mice on day 21.

3.5. Effects of Dietary I3C on AhR and Immune Markers in Colonic Tissues.

In agreement with previous studies, consumption of 1 µmol I3C/g diet significantly induced the expression of AhR-responsive genes including cytochrome P450 1A1 (CYP1A1) and 1B1 (CYP1B1) mRNA in colonic tissues. As compared to the control group, the expression of CYP1A1 and CYP1B1 mRNA was about 93 and 5 times higher in the I3C group, respectively (Figure 4). Cr infection had no effect on the expression of either CYP1A1 or CYP1B1 mRNA in mice fed the control diet but decreased expression of CYP1A1 mRNA in the mice fed the I3C diet (Figure 4).
As shown in Figure 5, mice infected with Cr had increased expression of multiple cytokines including IL-17A, IL-22, IL-6, and IL-1β mRNA in colonic tissue 12 days after infection. Cr-induced expression of IL-17A, IL-6, and IL-1β mRNA were significantly attenuated in infected mice that were fed on the I3C diet. However, there was no effect by I3C on a Cr-induced increase of IL-22 mRNA.
In addition to inflammatory marker genes closely associated with Cr-induced innate immunity, marker genes for the cytotoxic T cell and Treg cell were also determined. As illustrated in Figure 5, the expression of cytotoxic T cell markers CD8a, CD8b, and FasL mRNA were upregulated by the infection with Cr in colonic tissue. Importantly, I3C-fed Cr-infected mice have enhanced expression of all the aforementioned genes in the colonic tissue compared to Cr-infected mice fed control diet. Furthermore, gene expression of Foxp3, a transcriptional factor and specific marker of T regulatory cells that produces IL-10 [29], was significantly increased in the infected mice fed with the I3C diet in the colonic tissue (Figure 5). Consistent with this, mice fed with the I3C diet also had enhanced Cr-induced IL-10 mRNA expression in the colonic tissue of infected mice (Figure 5).

3.6. I3C Inhibited C. rodentium Growth

I3C has been reported to exhibit broad spectrum anti-microbial properties in vitro [12]. To test whether I3C can inhibit growth of Cr directly, the in vitro effect of I3C on Cr growth was investigated in both aerobic and anaerobic conditions. The concentration of I3C applied in this study was based on the reported minimum inhibitory concentration (40 μg/mL) of I3C for Escherichia coli [12]. I3C significantly inhibited Cr growth under anaerobic conditions in a dose-dependent manner (Figure 6) compared to the vehicle control (Ethanol). Under aerobic conditions, growth only appeared to be delayed as the growth rates were nearly identical (as indicated by parallel growth curves) starting at about 4 h.

3.7. I3C- and DIM-Inhibited Cr Adhesion to Caco-2 Cells

The effects of I3C (0–100 μM) and DIM (0–25 μM) on Cr adhesion to intestinal epithelial cells were also evaluated using a Caco-2 cell adhesion model. The concentrations of I3C and DIM used were not toxic to the Caco-2 cells. Both I3C and DIM treatment led to a dose-dependent inhibition of Cr adhesion to Caco-2 cells (Figure 7). Significant inhibition of bacterial adhesion was observed at 25 µM I3C and above, with an IC50 value of 35.2 μM. For DIM, significant inhibition was observed at 10 μM DIM and above, with an IC50 of 18.5 μM.

4. Discussion

The current study identified several novel observations related to the effects of I3C on Cr infection, specifically: (1) I3C or its bioactive derivative DIM can affect Cr growth and adhesion to intestinal cells in vitro; (2) dietary consumption of I3C enhanced cytotoxic T cell and Treg cell-related markers upon Cr infection; and (3) reduced colonic hyperplasia and the pro-inflammatory cytokine response. These data support the notion that dietary I3C or cruciferous vegetables may reduce intestinal infection-induced inflammation, a major risk factor for CRC. We postulate I3C may exert its protective effects through multiple mechanisms that include affecting bacterial growth and adhesion, as well as the immune response mediated by AhR. A working model summarized our observation is illustrated in Figure 8.
Most studies related to the protective effects of I3C on Cr infection have focused on modulation of the host immune responses by I3C. However, our result supports the idea that I3C may also be modulating Cr growth and adhesion to intestinal tissue in vitro. Firstly, I3C/DIM inhibits Cr growth under anaerobic conditions and secondly, I3C/DIM can prevent adhesion of Cr to intestinal epithelial cells in vitro. This notion is further supported by observing attenuated Cr loads in feces and colon of mice fed with a I3C diet (Figure 1). Lower bacterial loads would lead to lower immune responses and therefore the observed effects of I3C on attenuation of Cr-induced IL-1β, IL-6, and IL-17A levels could also be the result of a reduced Cr load. Alternatively, IL-10 and FoxP3 expression were upregulated in infected I3C mice compared to infected controls, and may have contributed to the decreased pro-inflammatory response. The mechanisms underlying the protective effects of I3C on Cr infection may be multiple. Recent studies indicated that I3C can modulate host immune responses as an AhR ligand and afford protective effects against Cr infection [17,30,31]. Signaling through the AhR receptor was reported to be a requirement for clearance of Cr infections. AhR knock-out mice are susceptible to lethal infection by Cr [16]. Furthermore, AhR ligand-deficient mice have increased susceptibility to lethal infection by Cr, but this can be reversed by administering I3C [32]. Our results showing that I3C induced an increase in CYP1A1 and CYP1B1 mRNA, two well-documented AhR-responsive genes, confirm that the AhR pathway is indeed activated in the intestinal tissues of mice, which may include intestinal cells as well as inflammation-related immune cells. Therefore, consistent with reported literature, activation of an AhR-mediated host immune system is an additional mechanism by which I3C may exert its Cr infection/inflammation protective effects. This is consistent with the downregulation of several pro-inflammatory genes including IL-6, IL-17A, and IL-1β in I3C-treated Cr-infected mice compared to Cr-infected mice fed on the control diet. However, our results on I3C/DIM’s effect on Cr growth and adhesion suggest an additional explanation for the observations in AhR knockout mice and support the concept that I3C may also act through mechanisms proximal to activation of host immune system to protect against Cr infection and inflammation.
Ingestion of dietary I3C reduced Cr levels in the feces and colon of mice in the present study. Furthermore, I3C reduced infection-induced colon hyperplasia on day 12 but not on day 21. Reduced colon hypertrophy correlated with a reduction in pro-inflammatory cytokine production, an increase in the expression of IL-10, and enhanced expression of the Treg marker Foxp3 as well as the cytotoxic T-cell markers CD8a, CD8b, and FasL. These data further support dietary I3C or cruciferous vegetable in moderating the impact of infectious colitis. Cr colonization elicits a robust T cell response in the colon [22,33]. The number of CD4+ T cells and CD8+ T cells was reported to peak on day 14 post infection [34,35]. The role of CD4+ T cells in immunity for Cr is well known [22], but there are relatively fewer studies on the role of cytotoxic T cell (CD8+ T cell) and Treg cell in Cr infection. Data presented here for cytotoxic T cell and Treg markers support the notion that there is also a role for I3C in modulating immune pathways related to these cells. At day 12 post infection, the observed increase in gene expression of CD8a, CD8b, and FasL mRNA indicates that the cytotoxic T cell pathway was upregulated in the colon of Cr-infected mice. More importantly, infected mice fed the I3C diet exhibited a higher expression of CD8a, CD8b, and FasL genes than infected mice fed on the control diet. These results indicate that I3C may enhance the cytotoxic T cell response and may be beneficial for protecting against colon inflammation and therefore carcinogenesis. Recent advances in cancer immunotherapy indicate that activating cytotoxic T cells may be an effective strategy for treating cancer [36] and I3C enhancement of cytotoxic T cell responses would complement such immune therapy.
Given the role of Treg in the resolution of inflammation, increased colonic expression of the Treg marker Foxp3 and IL-10 by dietary I3C may have contributed to a reduction in hyperplasia by dampening the pro-inflammatory response. These data are consistent with a previous study that documented AhR activation triggered Treg cell during DSS-induced colitis and support regulation of Treg as an additional mechanism by which I3C can protect against Cr infection. Additional studies are needed to fully elucidate the role of Treg in the protective effects of I3C. The role of Treg in colon cancer development remain paradoxical and both pro- and anti-tumorigenic roles have been reported. Recently, it was reported that tumor-infiltrating Foxp3 Tregs predict a favorable outcome in colorectal cancer patients. Moreover, to explain the paradoxical role, it was proposed that Treg regulation by the gut microbiome/bacteria may provide protection against colon cancer. Hence, up-regulation of Treg by I3C as observed in our system may be relevant in preventing colon cancer and warrants further investigation.

5. Conclusions

In summary, the data presented here supports a protective role of I3C in Cr-induced infection/inflammation and thus, by inference, may reduce the risk of CRC. In addition to immunomodulatory effects on Cr infections, I3C may also affect growth and adhesion of Cr. Our results also indicate regulation of cytotoxic T cell and Treg cells as additional molecular mechanisms that may be regulated by I3C which can lead to overall anti-inflammatory and anti-colon cancer potential.

Supplementary Materials

The following are available online at https://0-www-mdpi-com.brum.beds.ac.uk/2072-6643/12/4/917/s1, Figure S1: Effect of Cr infection on body weight (A) and food consumption (B) in uninfected or infected mice fed on a control or I3C diet. The body weight of mice on different days was normalized to each animal’s body weight on day 0. Infection with Cr was initiated on day 15 after the start of the diet. Results were expressed as mean +/− SD (n = 8). Figure S2: Fecal excretion of Cr. The feces of mice were collected on day 20 after infection and the Log cfu/g feces determined set. Results were expressed as mean +/− SD (n = 8). Figure S3: Representative images of H&E-stained colon sections of uninfected and Cr-infected mice fed on a control or I3C diet. The colon tissues were collected from day 12 (a, b, c, d) and day 21(e, f, g, h) after infection. Original magnification ×100. (a, e): uninfected mice fed with a control diet (Ctrl); (b, f): infected mice fed with a control diet (Ctrl-Cr); (c, g): uninfected mice fed with I3C diet (I3C); (d, h): infected mice fed with I3C diet (I3C-Cr). The colonic hyperplasia and the goblet cell loss were found in the mice infected with Cr, the damage of colon recovered on 21 days post infection. I3C could hae ameliorated the damage caused by the infection on day 12.

Author Contributions

T.T.Y.W. and A.D.S. designed the experiment; Y.W., A.D.S., and L.C. performed the animal experiment; Y.W. performed the data analysis; Y.W., Q.P., Q.H., L.Y., Y.S.K. and T.T.Y.W. participated in the writing, review, and/or revision of the manuscript; T.T.Y.W. and A.D.S. supervised this study. All authors have read and agreed to the published version of the manuscript.

Funding

This study was supported by U.S. Department of Agriculture appropriated fund #8040-51530-056-00D, non-funded cooperative agreement between USDA and Sichuan University, foundation for Young Scientist of Beijing Technology & Business University (Grant QNJJ2020-11). This work was also supported by an interagency agreement between USDA and the National Cancer Institute, Nutrition Research Group.

Acknowledgments

The authors thank Harold Seifried, National Cancer Institute, Nutrition Research Group, for critically reading of the manuscript.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Bray, F.; Ferlay, J.; Soerjomataram, I.; Siegel, R.L.; Torre, L.A.; Jemal, A. Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J. Clin. 2018, 68, 394–424. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Terzić, J.; Grivennikov, S.; Karin, E.; Karin, M. Inflammation and colon cancer. Gastroenterology 2010, 138, 2101–2114. [Google Scholar] [CrossRef] [PubMed]
  3. Janakiram, N.B.; Rao, C.V. The role of inflammation in colon cancer. In Inflammation and Cancer; Springer: Berlin/Heidelberg, Germany, 2014; pp. 25–52. [Google Scholar]
  4. Abdulamir, A.S.; Hafidh, R.R.; Bakar, F.A. The association of Streptococcus bovis/gallolyticus with colorectal tumors: The nature and the underlying mechanisms of its etiological role. J. Exp. Clin. Cancer Res. 2011, 30, 11. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Sobhani, I.; Amiot, A.; Le Baleur, Y.; Levy, M.; Auriault, M.-L.; Van Nhieu, J.T.; Delchier, J.C. Microbial dysbiosis and colon carcinogenesis: Could colon cancer be considered a bacteria-related disease? Therap. Adv. Gastroenterol. 2013, 6, 215–229. [Google Scholar] [CrossRef] [Green Version]
  6. Rustgi, A.K. The genetics of hereditary colon cancer. Genes Dev. 2007, 21, 2525–2538. [Google Scholar] [CrossRef] [Green Version]
  7. Akin, H.; Tozun, N. Diet, microbiota, and colorectal cancer. J. Clin. Gastroenterol. 2014, 48, S67–S69. [Google Scholar] [CrossRef]
  8. Terry, P.; Giovannucci, E.; Michels, K.B.; Bergkvist, L.; Hansen, H.; Holmberg, L.; Wolk, A. Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J. Natl. Cancer Inst. 2001, 93, 525–533. [Google Scholar] [CrossRef] [Green Version]
  9. Keck, A.-S.; Finley, J.W. Cruciferous vegetables: Cancer protective mechanisms of glucosinolate hydrolysis products and selenium. Integr. Cancer Ther. 2004, 3, 5–12. [Google Scholar] [CrossRef]
  10. Wang, T.T.Y.; Schoene, N.W.; Milner, J.A.; Kim, Y.S. Broccoli-derived phytochemicals indole-3-carbinol and 3, 3′-diindolylmethane exerts concentration-dependent pleiotropic effects on prostate cancer cells: Comparison with other cancer preventive phytochemicals. Mol. Carcinog. 2012, 51, 244–256. [Google Scholar] [CrossRef]
  11. Broadbent, T.A.; Broadbent, H.S. The chemistry and pharmacology of indole-3-carbinol (indole-3-methanol) and 3-(methoxymethyl) indole. [Part I]. Curr. Med. Chem. 1998, 5, 469–491. [Google Scholar]
  12. Sung, W.S.; Lee, D.G. In vitro antimicrobial activity and the mode of action of indole-3-carbinol against human pathogenic microorganisms. Biol. Pharm. Bull. 2007, 30, 1865–1869. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  13. Acharya, A.; Das, I.; Singh, S.; Saha, T. Chemopreventive properties of indole-3-carbinol, diindolylmethane and other constituents of cardamom against carcinogenesis. Recent Pat. Food. Nutr. Agric. 2010, 2, 166–177. [Google Scholar] [CrossRef] [PubMed]
  14. Aggarwal, B.B.; Ichikawa, H. Molecular targets and anticancer potential of indole-3-carbinol and its derivatives. Cell Cycle 2005, 4, 1201–1215. [Google Scholar] [CrossRef] [Green Version]
  15. Huang, Z.; Jiang, Y.; Yang, Y.; Shao, J.; Sun, X.; Chen, J.; Dong, L.; Zhang, J. 3, 3′-Diindolylmethane alleviates oxazolone-induced colitis through Th2/Th17 suppression and Treg induction. Mol. Immunol. 2013, 53, 335–344. [Google Scholar] [CrossRef] [PubMed]
  16. Kiss, E.A.; Vonarbourg, C.; Kopfmann, S.; Hobeika, E.; Finke, D.; Esser, C.; Diefenbach, A. Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles. Science 2011, 334, 1561–1565. [Google Scholar] [CrossRef]
  17. Schiering, C.; Wincent, E.; Metidji, A.; Iseppon, A.; Li, Y.; Potocnik, A.J.; Omenetti, S.; Henderson, C.J.; Wolf, C.R.; Nebert, D.W. Feedback control of AHR signalling regulates intestinal immunity. Nature 2017, 542, 242. [Google Scholar] [CrossRef] [Green Version]
  18. Petty, N.K.; Bulgin, R.; Crepin, V.F.; Cerdeño-Tárraga, A.M.; Schroeder, G.N.; Quail, M.A.; Lennard, N.; Corton, C.; Barron, A.; Clark, L. The Citrobacter rodentium genome sequence reveals convergent evolution with human pathogenic Escherichia coli. J. Bacteriol. 2010, 192, 525–538. [Google Scholar] [CrossRef] [Green Version]
  19. Silberger, D.J.; Zindl, C.L.; Weaver, C.T. Citrobacter rodentium: A model enteropathogen for understanding the interplay of innate and adaptive components of type 3 immunity. Mucosal Immunol. 2017, 10, 1108. [Google Scholar] [CrossRef] [Green Version]
  20. Collins, J.W.; Keeney, K.M.; Crepin, V.F.; Rathinam, V.A.K.; Fitzgerald, K.A.; Finlay, B.B.; Frankel, G. Citrobacter rodentium: Infection, inflammation and the microbiota. Nat. Rev. Microbiol. 2014, 12, 612. [Google Scholar] [CrossRef]
  21. Ota, N.; Wong, K.; Valdez, P.A.; Zheng, Y.; Crellin, N.K.; Diehl, L.; Ouyang, W. IL-22 bridges the lymphotoxin pathway with the maintenance of colonic lymphoid structures during infection with Citrobacter rodentium. Nat. Immunol. 2011, 12, 941. [Google Scholar] [CrossRef]
  22. Simmons, C.P.; Clare, S.; Ghaem-Maghami, M.; Uren, T.K.; Rankin, J.; Huett, A.; Goldin, R.; Lewis, D.J.; MacDonald, T.T.; Strugnell, R.A. Central role for B lymphocytes and CD4+ T cells in immunity to infection by the attaching and effacing pathogen Citrobacter rodentium. Infect. Immun. 2003, 71, 5077–5086. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  23. Spits, H.; Artis, D.; Colonna, M.; Diefenbach, A.; Di Santo, J.P.; Eberl, G.; Koyasu, S.; Locksley, R.M.; McKenzie, A.N.J.; Mebius, R.E. Innate lymphoid cells—A proposal for uniform nomenclature. Nat. Rev. Immunol. 2013, 13, 145. [Google Scholar] [CrossRef] [PubMed]
  24. Kassie, F.; Matise, I.; Negia, M.; Upadhyaya, P.; Hecht, S.S. Dose-dependent inhibition of tobacco smoke carcinogen–induced lung tumorigenesis in A/J mice by indole-3-carbinol. Cancer Prev. Res. 2008, 1, 568–576. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  25. Fletcher, A.; Huang, H.; Yu, L.; Pham, Q.; Yu, L.; Wang, T.T.Y. Reversible toxic effects of the dietary supplement Indole-3-carbinol in an immune compromised rodent model: Intestine as the main target. J. Diet. Suppl. 2017, 14, 303–322. [Google Scholar] [CrossRef] [PubMed]
  26. Reed, G.A.; Arneson, D.W.; Putnam, W.C.; Smith, H.J.; Gray, J.C.; Sullivan, D.K.; Mayo, M.S.; Crowell, J.A.; Hurwitz, A. Single-dose and multiple-dose administration of indole-3-carbinol to women: Pharmacokinetics based on 3, 3′-diindolylmethane. Cancer Epidemiol. Prev. Biomark. 2006, 15, 2477–2481. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  27. Cho, G.-S.; Ritzmann, F.; Eckstein, M.; Huch, M.; Briviba, K.; Behsnilian, D.; Neve, H.; Franz, C.M.A.P. Quantification of Slackia and Eggerthella spp. in human feces and adhesion of representatives strains to Caco-2 cells. Front. Microbiol. 2016, 7, 658. [Google Scholar] [CrossRef] [Green Version]
  28. Wiles, S.; Clare, S.; Harker, J.; Huett, A.; Young, D.; Dougan, G.; Frankel, G. Organ specificity, colonization and clearance dynamics in vivo following oral challenges with the murine pathogen Citrobacter rodentium. Cell. Microbiol. 2004, 6, 963–972. [Google Scholar] [CrossRef]
  29. Hori, S.; Nomura, T.; Sakaguchi, S. Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299, 1057–1061. [Google Scholar] [CrossRef] [Green Version]
  30. Esser, C.; Rannug, A.; Stockinger, B. The aryl hydrocarbon receptor in immunity. Trends Immunol. 2009, 30, 447–454. [Google Scholar] [CrossRef]
  31. Mohammadi, S.; Seyedhosseini, F.S.; Behnampour, N.; Yazdani, Y. Indole-3-carbinol induces G1 cell cycle arrest and apoptosis through aryl hydrocarbon receptor in THP-1 monocytic cell line. J. Recept. Signal Transduct. 2017, 37, 506–514. [Google Scholar] [CrossRef]
  32. Li, Y.; Innocentin, S.; Withers, D.R.; Roberts, N.A.; Gallagher, A.R.; Grigorieva, E.F.; Wilhelm, C.; Veldhoen, M. Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation. Cell 2011, 147, 629–640. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  33. Vallance, B.A.; Deng, W.; Knodler, L.A.; Finlay, B.B. Mice lacking T and B lymphocytes develop transient colitis and crypt hyperplasia yet suffer impaired bacterial clearance during Citrobacter rodentium infection. Infect. Immun. 2002, 70, 2070–2081. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  34. Bergstrom, K.S.B.; Morampudi, V.; Chan, J.M.; Bhinder, G.; Lau, J.; Yang, H.; Ma, C.; Huang, T.; Ryz, N.; Sham, H.P. Goblet cell derived RELM-β recruits CD4+ T cells during infectious colitis to promote protective intestinal epithelial cell proliferation. PLoS Pathog. 2015, 11, e1005108. [Google Scholar] [CrossRef] [PubMed]
  35. Crepin, V.F.; Collins, J.W.; Habibzay, M.; Frankel, G. Citrobacter rodentium mouse model of bacterial infection. Nat. Protoc. 2016, 11, 1851. [Google Scholar] [CrossRef]
  36. Nair, S.K.; Heiser, A.; Boczkowski, D.; Majumdar, A.; Naoe, M.; Lebkowski, J.S.; Vieweg, J.; Gilboa, E. Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat. Med. 2000, 6, 1011. [Google Scholar] [CrossRef]
Nutrients 12 00917 g001 550
Figure 1. Effect of Indole-3-carbinol (I3C) on fecal and colonic Citrobacter rodentium (Cr) in mice. Mice were infected orally with approximately 1.0 × 1010 CFU of C. rodentium. (A): Fecal excretion of Cr. The feces of mice were collected on day 11 after infection and the Log cfu/g feces determined set; (B): Colonic colonization of C. rodentium. Mice were sacrificed on day 12 post infection and the Log cfu/g colon tissue was determined. Results were expressed as mean +/− SD (n = 8). * indicates significantly different from control (p < 0.05).
Figure 1. Effect of Indole-3-carbinol (I3C) on fecal and colonic Citrobacter rodentium (Cr) in mice. Mice were infected orally with approximately 1.0 × 1010 CFU of C. rodentium. (A): Fecal excretion of Cr. The feces of mice were collected on day 11 after infection and the Log cfu/g feces determined set; (B): Colonic colonization of C. rodentium. Mice were sacrificed on day 12 post infection and the Log cfu/g colon tissue was determined. Results were expressed as mean +/− SD (n = 8). * indicates significantly different from control (p < 0.05).
Nutrients 12 00917 g001
Nutrients 12 00917 g002 550
Figure 2. Cr infection resulted in an increase in colon weight on day 12 and 21 post infection but had no impact on spleen and cecum weight. Colon, spleen and cecum samples were collected and weighed on day 12 (A) and day 21 (B) after infection. Results were expressed as mean +/− SD (n = 8). Diet had no effect on tissue weights in either uninfected or Cr-infected mice. Significant differences (p < 0.05) between groups were identified by different letters.
Figure 2. Cr infection resulted in an increase in colon weight on day 12 and 21 post infection but had no impact on spleen and cecum weight. Colon, spleen and cecum samples were collected and weighed on day 12 (A) and day 21 (B) after infection. Results were expressed as mean +/− SD (n = 8). Diet had no effect on tissue weights in either uninfected or Cr-infected mice. Significant differences (p < 0.05) between groups were identified by different letters.
Nutrients 12 00917 g002
Nutrients 12 00917 g003 550
Figure 3. I3C reduces colonic hyperplasia at day 12 but not day 21 post infection. Colon tissue was collected on day 12 (A) and day 21 (B) after infection and processed for H&E staining. Mucosa height was measured on well-oriented crypts and 12 or more individual measurements were averaged for each mouse. Results were expressed as mean +/− SD (n = 8). Significant differences (p < 0.05) between groups are identified by different letters.
Figure 3. I3C reduces colonic hyperplasia at day 12 but not day 21 post infection. Colon tissue was collected on day 12 (A) and day 21 (B) after infection and processed for H&E staining. Mucosa height was measured on well-oriented crypts and 12 or more individual measurements were averaged for each mouse. Results were expressed as mean +/− SD (n = 8). Significant differences (p < 0.05) between groups are identified by different letters.
Nutrients 12 00917 g003
Nutrients 12 00917 g004 550
Figure 4. Xenobiotic metabolizing enzyme genes were upregulated in colons of mice fed the I3C diet. Total RNA isolated from colon tissues were harvested on day 12 after infection. The expression of cytochrome P450 1A1 (CYP1A1) and 1B1 (CYP1B1) enzyme genes were determined by using real-timeRT-PCR. Results were expressed as mean +/− SD (n = 8). Different letters indicated significant differences between groups for each tissue (p < 0.05).
Figure 4. Xenobiotic metabolizing enzyme genes were upregulated in colons of mice fed the I3C diet. Total RNA isolated from colon tissues were harvested on day 12 after infection. The expression of cytochrome P450 1A1 (CYP1A1) and 1B1 (CYP1B1) enzyme genes were determined by using real-timeRT-PCR. Results were expressed as mean +/− SD (n = 8). Different letters indicated significant differences between groups for each tissue (p < 0.05).
Nutrients 12 00917 g004
Nutrients 12 00917 g005 550
Figure 5. Effect of dietary I3C on Cr-infection-induced inflammation and immune cell markers gene expression in colon. RT-PCR was performed on total RNA isolated from colon tissues harvested on day 12 post infection. Results are expressed as the mean +/− SD fold-change (n = 8). Groups with different letters are significantly different. (p < 0.05).
Figure 5. Effect of dietary I3C on Cr-infection-induced inflammation and immune cell markers gene expression in colon. RT-PCR was performed on total RNA isolated from colon tissues harvested on day 12 post infection. Results are expressed as the mean +/− SD fold-change (n = 8). Groups with different letters are significantly different. (p < 0.05).
Nutrients 12 00917 g005
Nutrients 12 00917 g006 550
Figure 6. Effect of I3C on Cr growth in vitro. Cr (2 × 107 cfu/mL in LB medium) were grown in the presence of carrier (ethanol), 0.5 or 1.0 mM I3C at 37 °C with shaking under aerobic or anaerobic conditions. OD 600 nm values were determined every hour after incubation by using microtiter plate reader. Data expressed as mean OD value ± SD (n = 8).
Figure 6. Effect of I3C on Cr growth in vitro. Cr (2 × 107 cfu/mL in LB medium) were grown in the presence of carrier (ethanol), 0.5 or 1.0 mM I3C at 37 °C with shaking under aerobic or anaerobic conditions. OD 600 nm values were determined every hour after incubation by using microtiter plate reader. Data expressed as mean OD value ± SD (n = 8).
Nutrients 12 00917 g006
Nutrients 12 00917 g007 550
Figure 7. Effects of I3C and 3,3′-diindolylmethane (DIM) on adhesion of Cr to Caco-2 cell in vitro. Caco-2 cells were seeded in 24-well plates for 2 days and then co-cultured with the bacteria in the presence of I3C or DIM for 1 h. After incubation, the bacteria adherent to the cells were counted as described in the Materials and Methods section. Results expressed as mean +/− SD (n = 4) are shown as the percentage of Cr attachment relative to control cultures. * indicates significantly different from control (p < 0.05).
Figure 7. Effects of I3C and 3,3′-diindolylmethane (DIM) on adhesion of Cr to Caco-2 cell in vitro. Caco-2 cells were seeded in 24-well plates for 2 days and then co-cultured with the bacteria in the presence of I3C or DIM for 1 h. After incubation, the bacteria adherent to the cells were counted as described in the Materials and Methods section. Results expressed as mean +/− SD (n = 4) are shown as the percentage of Cr attachment relative to control cultures. * indicates significantly different from control (p < 0.05).
Nutrients 12 00917 g007
Nutrients 12 00917 g008 550
Figure 8. Working model for protective effects of I3C/DIM on infection, inflammation and cancer. I3C/DIM exert its protective effects through multiple mechanisms that include affecting bacterial growth, adhesion as well as immune responses mediated by AhR. Overall, the effects lead to decreased inflammation and protection against cancer.
Figure 8. Working model for protective effects of I3C/DIM on infection, inflammation and cancer. I3C/DIM exert its protective effects through multiple mechanisms that include affecting bacterial growth, adhesion as well as immune responses mediated by AhR. Overall, the effects lead to decreased inflammation and protection against cancer.
Nutrients 12 00917 g008
Table
Table 1. The list of PCR primers used in this study.
Table 1. The list of PCR primers used in this study.
PrimersCatalog NumberPrimersCatalog Number
TATA-box binding protein (TBP)Mm00446971_m1IL-1βMm00434228_m1
CYP1A1Mm00487217_m1CD8a1Mm01182108_m1
CYP1B1Mm00487229_m1CD8b1Mm00438116_m1
IL-17AMm00439618_m1FasLMm00438864_m1
IL-22Mm01226722_g1IL-10Mm00439614_m1
IL-6Mm00446190_m1Foxp3Mm00475162_m1

Share and Cite

MDPI and ACS Style

Wu, Y.; He, Q.; Yu, L.; Pham, Q.; Cheung, L.; Kim, Y.S.; Wang, T.T.Y.; Smith, A.D. Indole-3-Carbinol Inhibits Citrobacter rodentium Infection through Multiple Pathways Including Reduction of Bacterial Adhesion and Enhancement of Cytotoxic T Cell Activity. Nutrients 2020, 12, 917. https://0-doi-org.brum.beds.ac.uk/10.3390/nu12040917

AMA Style

Wu Y, He Q, Yu L, Pham Q, Cheung L, Kim YS, Wang TTY, Smith AD. Indole-3-Carbinol Inhibits Citrobacter rodentium Infection through Multiple Pathways Including Reduction of Bacterial Adhesion and Enhancement of Cytotoxic T Cell Activity. Nutrients. 2020; 12(4):917. https://0-doi-org.brum.beds.ac.uk/10.3390/nu12040917

Chicago/Turabian Style

Wu, Yanbei, Qiang He, Liangli Yu, Quynhchi Pham, Lumei Cheung, Young S. Kim, Thomas T. Y. Wang, and Allen D. Smith. 2020. "Indole-3-Carbinol Inhibits Citrobacter rodentium Infection through Multiple Pathways Including Reduction of Bacterial Adhesion and Enhancement of Cytotoxic T Cell Activity" Nutrients 12, no. 4: 917. https://0-doi-org.brum.beds.ac.uk/10.3390/nu12040917

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop